Constantine Davides
Stock Analyst at Citizens JMP
(0.10)
# 4,685
Out of 5,004 analysts
176
Total ratings
36.4%
Success rate
-12.4%
Average return
Main Sectors:
Stocks Rated by Constantine Davides
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| PGNY Progyny | Reiterated: Buy | $31 → $33 | $25.44 | +29.72% | 9 | Sep 8, 2026 | |
| NRC NRC Health | Reiterated: Buy | $23 → $26 | $19.57 | +32.86% | 2 | Jul 29, 2026 | |
| OMDA Omada Health | Reiterated: Buy | $21 → $27 | $19.66 | +37.33% | 3 | Jul 20, 2026 | |
| HQY HealthEquity | Reiterated: Buy | $122 → $111 | $88.25 | +25.78% | 9 | Jun 1, 2026 | |
| USPH U.S. Physical Therapy | Reiterated: Buy | $113 → $98 | $84.84 | +15.51% | 6 | May 8, 2026 | |
| ADUS Addus HomeCare | Reiterated: Buy | $150 → $142 | $113.19 | +25.45% | 8 | May 6, 2026 | |
| OPCH Option Care Health | Reiterated: Buy | $38 → $32 | $23.07 | +38.71% | 17 | Apr 30, 2026 | |
| AMN AMN Healthcare Services | Reiterated: Buy | $22 → $24 | $34.56 | -30.56% | 18 | Feb 23, 2026 | |
| WAY Waystar Holding | Reiterated: Buy | $48 → $34 | $24.70 | +37.65% | 3 | Feb 18, 2026 | |
| EVH Evolent Health | Reiterated: Buy | $11 → $10 | $3.61 | +177.01% | 14 | Jan 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $23 → $24 | $8.04 | +198.51% | 14 | Nov 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $30 → $31 | $19.71 | +57.28% | 11 | Nov 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $18.46 | n/a | 6 | Jul 15, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $9.11 | n/a | 7 | May 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $80.73 | n/a | 9 | Apr 28, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $29.10 | n/a | 6 | Feb 25, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $18 | $1.66 | n/a | 1 | May 25, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $125 | $2.81 | n/a | 5 | May 16, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $19 | $0.2774 | n/a | 1 | May 16, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $15 | $27.88 | n/a | 3 | May 11, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $23 | $20.75 | n/a | 4 | May 10, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $5.25 | $1.44 | n/a | 2 | Apr 18, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $6 | $0.0001 | n/a | 3 | Mar 30, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $8.5 | $2.05 | n/a | 1 | Mar 20, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $6 | $0.259 | n/a | 2 | Mar 16, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $15 | $2.12 | n/a | 2 | Feb 15, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $50 → $33 | $0.7678 | n/a | 3 | Dec 30, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $68 | $0.496 | n/a | 1 | Oct 18, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $14 → $8 | $1.61 | n/a | 2 | Sep 28, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $4.25 | $1.26 | n/a | 1 | Sep 23, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $2.3 | $0.4992 | n/a | 1 | Aug 18, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $4 | $0.778 | n/a | 1 | Mar 14, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $41 | $52.61 | n/a | 1 | Sep 27, 2011 |
Progyny
Sep 8, 2026
Reiterated: Buy
Price Target: $31 → $33
Current: $25.44
Upside: +29.72%
NRC Health
Jul 29, 2026
Reiterated: Buy
Price Target: $23 → $26
Current: $19.57
Upside: +32.86%
Omada Health
Jul 20, 2026
Reiterated: Buy
Price Target: $21 → $27
Current: $19.66
Upside: +37.33%
HealthEquity
Jun 1, 2026
Reiterated: Buy
Price Target: $122 → $111
Current: $88.25
Upside: +25.78%
U.S. Physical Therapy
May 8, 2026
Reiterated: Buy
Price Target: $113 → $98
Current: $84.84
Upside: +15.51%
Addus HomeCare
May 6, 2026
Reiterated: Buy
Price Target: $150 → $142
Current: $113.19
Upside: +25.45%
Option Care Health
Apr 30, 2026
Reiterated: Buy
Price Target: $38 → $32
Current: $23.07
Upside: +38.71%
AMN Healthcare Services
Feb 23, 2026
Reiterated: Buy
Price Target: $22 → $24
Current: $34.56
Upside: -30.56%
Waystar Holding
Feb 18, 2026
Reiterated: Buy
Price Target: $48 → $34
Current: $24.70
Upside: +37.65%
Evolent Health
Jan 6, 2026
Reiterated: Buy
Price Target: $11 → $10
Current: $3.61
Upside: +177.01%
Nov 7, 2025
Reiterated: Buy
Price Target: $23 → $24
Current: $8.04
Upside: +198.51%
Nov 7, 2025
Reiterated: Buy
Price Target: $30 → $31
Current: $19.71
Upside: +57.28%
Jul 15, 2025
Reiterated: Hold
Price Target: n/a
Current: $18.46
Upside: n/a
May 6, 2025
Reiterated: Hold
Price Target: n/a
Current: $9.11
Upside: n/a
Apr 28, 2025
Reiterated: Hold
Price Target: n/a
Current: $80.73
Upside: n/a
Feb 25, 2025
Reiterated: Hold
Price Target: n/a
Current: $29.10
Upside: n/a
May 25, 2023
Initiated Coverage: Buy
Price Target: $18
Current: $1.66
Upside: n/a
May 16, 2023
Reiterated: Buy
Price Target: $125
Current: $2.81
Upside: n/a
May 16, 2023
Reiterated: Buy
Price Target: $19
Current: $0.2774
Upside: n/a
May 11, 2023
Reiterated: Buy
Price Target: $15
Current: $27.88
Upside: n/a
May 10, 2023
Reiterated: Buy
Price Target: $23
Current: $20.75
Upside: n/a
Apr 18, 2023
Reiterated: Buy
Price Target: $5.25
Current: $1.44
Upside: n/a
Mar 30, 2023
Reiterated: Buy
Price Target: $6
Current: $0.0001
Upside: n/a
Mar 20, 2023
Initiated Coverage: Buy
Price Target: $8.5
Current: $2.05
Upside: n/a
Mar 16, 2023
Reiterated: Buy
Price Target: $6
Current: $0.259
Upside: n/a
Feb 15, 2023
Reiterated: Buy
Price Target: $15
Current: $2.12
Upside: n/a
Dec 30, 2022
Reiterated: Buy
Price Target: $50 → $33
Current: $0.7678
Upside: n/a
Oct 18, 2022
Initiated Coverage: Buy
Price Target: $68
Current: $0.496
Upside: n/a
Sep 28, 2022
Reiterated: Buy
Price Target: $14 → $8
Current: $1.61
Upside: n/a
Sep 23, 2022
Reiterated: Buy
Price Target: $4.25
Current: $1.26
Upside: n/a
Aug 18, 2022
Reiterated: Buy
Price Target: $2.3
Current: $0.4992
Upside: n/a
Mar 14, 2022
Initiated Coverage: Buy
Price Target: $4
Current: $0.778
Upside: n/a
Sep 27, 2011
Initiated Coverage: Buy
Price Target: $41
Current: $52.61
Upside: n/a